This study investigated biomarker levels and diagnostic utility of plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in NPC compared to healthy controls.<h4>Methods</h4>Patients with NPC were recruited from a specialist assessment and management service. The gene discussed is NEFL; the disease is nasopharyngeal carcinoma.